Compare Yei Finance (Clovis) (CLO) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Yei Finance (Clovis) vs Mira — how do they compare? Yei Finance (Clovis) trades at Rp2,056 (market cap Rp266,37M, Rp30,08M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Yei Finance (Clovis) is the larger of the two by market cap, and Yei Finance (Clovis)'s circulating supply is 129,1M / 1B CLO (13%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Yei Finance (Clovis) for 3 Days and Mira for 22 Days on average.
| CLO | MIRA | |
|---|---|---|
Market Cap | Rp266,37M | Rp226,43M |
Volume (24h) | Rp30,08M | Rp101,47M |
Circulating Supply | 129,1M / 1B CLO (13%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 3 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Yei Finance (CLO) is currently trading at Rp2,048 with a bearish technical outlook as all 16 moving average signals indicate selling pressure. The token shows limited circulation at 13% of max supply and extremely short average hold time of 3 days. Current price sits near the pivot point of Rp2,022 with resistance at Rp2,174 and support at Rp1,900.
Overall outlook remains cautious due to weak technical indicators and low adoption metrics. Key opportunity lies in potential oversold bounce from support levels, while major risks include low liquidity, minimal network activity, and high volatility from concentrated holdings.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Yei Finance (Clovis)
Yei Finance (Clovis) is a liquidity abstraction layer designed to reunify fragmented capital across networks. It integrates cross-chain DEX, money markets, and bridging to provide on-demand global liquidity for multiple assets and chains. Its architecture enables liquidity providers to earn diversified yields while offering users near-instant cross-network transfers.
Read more on CLO →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
